For example, TP53 loss/mutations was found to be strongly associated with acquired and intrinsic resistance to CDK4/6 inhibition in patients (TP53 loss/mutation in 60% of resistant tumours and 0% of sensitive tumours)46. Here, CDK4 is linked to neoplasm.